Geo + Industry Hub
Healthcare Startups in United States
41 companies indexed with founder profiles, funding rounds, and hiring signals.
Related Geo and Industry Routes
Navigate from this geo+industry page to country news, stage hubs, and startup taxonomy pages.
Healthcare in United States: context for operators and investors
Geo + industry pages are useful when you need clarity on where a sector is actually gaining traction. This hub focuses only on Healthcare companies in United States, so comparisons are made between companies that share a similar market environment and regulatory context.
To complete the picture, pair this table with country directory, country news, and startup industry pages to benchmark both local execution and global category movement.
| Company | Founder | Funding | Last Round | Hiring |
|---|---|---|---|---|
| Tempo | Tempo Team | $220.00M | Series C Khosla Ventures, Founders Fund, Y Combinator, $220M Series C in 2021, $750M valuation | Open Roles |
| Neuralink | Neuralink Team | $205.00M | Series C Founders Fund, $205M Series C in 2021, $500M valuation | Open Roles |
| Cedar | Cedar Team | $200.00M | Series D Andreessen Horowitz, Founders Fund, $200M Series D in 2021, $3.2B valuation | Open Roles |
| SWORD Health | SWORD Health Team | $163.00M | Series D Founders Fund, Khosla Ventures, $163M Series D in 2021, $1.8B valuation | Open Roles |
| Scipher Medicine | Scipher Medicine Team | $110.00M | Series D Khosla Ventures, $110M Series D in 2022 | Open Roles |
| Calibrate | Calibrate Team | $100.00M | Series B Founders Fund, $100M Series B in 2021 | Open Roles |
| Forward | Forward Team | $100.00M | Series E Khosla Ventures, Founders Fund, $100M Series E in 2023 | Open Roles |
| Biofourmis | Biofourmis Team | $100.00M | Series C Sequoia, $100M Series C in 2020, $700M valuation | Open Roles |
| FightCamp | FightCamp Team | $90.00M | Series B Y Combinator, $90M Series B in 2021 | Open Roles |
| AKASA | AKASA Team | $80.00M | Series B Andreessen Horowitz, $80M Series B in 2021 | Open Roles |
| Florence Healthcare | Florence Healthcare Team | $80.00M | Series C Bessemer, $80M Series C in 2021 | Open Roles |
| Deepcell | Deepcell Team | $73.00M | Series B Andreessen Horowitz, $73M Series B in 2022 | Open Roles |
| Hinge Health | Hinge Health Team | $600.00M | Series E Bessemer, $600M Series E in 2021, $6.2B valuation | Open Roles |
| Nanotronics Imaging | Nanotronics Imaging Team | $46.00M | Series D Founders Fund, $46M Series D in 2021, $177M valuation | Open Roles |
| Solv Health | Solv Health Team | $45.00M | Series C Benchmark, $45M Series C in 2021 | Open Roles |
| Ribbon Health | Ribbon Health Team | $44.00M | Series B Andreessen Horowitz, Y Combinator, $44M Series B in 2021 | Open Roles |
| Valar Labs | Valar Labs Team | $4.00M | Seed Andreessen Horowitz, $4M Seed in 2022 | Open Roles |
| Zus Health | Zus Health Team | $40.00M | Series A Andreessen Horowitz, $40M Series A in 2023 | Open Roles |
| Devoted Health | Devoted Health Team | $362.00M | Series D Andreessen Horowitz, $362M Series D in 2021, $1.1B valuation | Open Roles |
| Sprinter Health | Sprinter Health Team | $32.00M | Series B Andreessen Horowitz, Accel, $32M Series B in 2025 | Open Roles |
| Abridge | Abridge Team | $316.00M | Series E Bessemer, Andreessen Horowitz, $316M Series E in 2025, $5.3B valuation | Open Roles |
| Camber | Camber Team | $30.00M | Series B Andreessen Horowitz, Y Combinator, $30M Series B in 2025 | Open Roles |
| Collective Health | Collective Health Team | $280.00M | Series F Founders Fund, $280M Series F in 2021, $1.5B valuation | Open Roles |
| Komodo Health | Komodo Health Team | $220.00M | Series E Andreessen Horowitz, $220M Series E in 2021, $3.0B valuation | Open Roles |
| Virta Health | Virta Health Team | $215.00M | Series E Founders Fund, $215M Series E in 2021, $1.1B valuation | Open Roles |
| Turquoise Health | Turquoise Health Team | $20.00M | Series A Andreessen Horowitz, Bessemer, $20M Series A in 2022 | Open Roles |
| Formation Bio | Formation Bio Team | $156.00M | Series C Sequoia, $156M Series C in 2021, $1.0B valuation | Open Roles |
| Ophelia | Ophelia Team | $15.00M | Series A Y Combinator, $15M Series A in 2021, $275M valuation | Open Roles |
| FidoCure | FidoCure Team | $15.00M | Series A Y Combinator, $15M Series A in 2020 | Open Roles |
| Truepill | Truepill Team | $142.00M | Series D Y Combinator, $142M Series D in 2021, $1.6B valuation | Open Roles |
| Naked Labs | Naked Labs Team | $14.00M | Series A Founders Fund, $14M Series A in 2018 | Open Roles |
| AliveCor | AliveCor Team | $128.00M | Series F Khosla Ventures, $128M Series F in 2022 | Open Roles |
| BillionToOne | BillionToOne Team | $125.00M | Series C Y Combinator, $125M Series C in 2022 | Open Roles |
| Inflammatix | Inflammatix Team | $102.00M | Series D Khosla Ventures, $102M Series D in 2021 | Open Roles |
| Dyno Therapeutics | Dyno Therapeutics Team | $100.00M | Series A Andreessen Horowitz, $100M Series A in 2021 | Open Roles |
| H1 | H1 Team | $100.00M | Series C Y Combinator, $100M Series C in 2021, $750M valuation | Open Roles |
| Color | Color Team | $100.00M | Series E Khosla Ventures, $100M Series E in 2021, $4.6B valuation | Open Roles |
| Benchling | Benchling Team | $100.00M | Series F Sequoia, Andreessen Horowitz, Benchmark, Y Combinator, $100M Series F in 2021, $6.1B valuation | Open Roles |
| Fractyl Labs | Fractyl Labs Team | $100.00M | Series F Bessemer, $100M Series F in 2021 | Open Roles |
| Nuna | Nuna Team | $90.00M | Series B Kleiner Perkins, $90M Series B in 2017 | Open Roles |
| Emulate | Emulate Team | $82.00M | Series E Founders Fund, $82M Series E in 2021 | Open Roles |